Jul 15, 2026 04:05PM
Jul 15, 2026 04:05PM
Jul 14, 2026 04:07PM
Jul 14, 2026 04:05PM
Mar 10, 2026 05:05PM
Sep 2, 2025 04:59AM
Sep 2, 2025 01:30AM QIAGEN Gains U.S. Clearance of Higher-Throughput QIAstat-Dx Rise, Expanding Patient Access to Rapid Syndromic Testing
Jun 15, 2025 04:00AM
Mar 6, 2025 01:00AM
Feb 5, 2025 04:05PM
Jan 9, 2025 04:05PM
Nov 28, 2024 06:00AM
Jul 31, 2024 04:06PM
May 30, 2024 05:55PM QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications
Oct 26, 2023 08:03AM
Aug 7, 2023 04:05PM
Mar 9, 2023 01:30AM
Feb 14, 2023 04:05PM
Jan 5, 2023 04:05PM
Jan 5, 2023 04:05PM
Dec 13, 2022 05:00AM QIAGEN receives FDA approval for companion diagnostic to Mirati Therapeutics’ KRAZATI in non-small cell lung cancer
Sep 14, 2022 04:05PM
Sep 14, 2022 04:01PM
Jul 27, 2022 01:40AM
Jan 6, 2022 04:05PM
Dec 9, 2021 09:30AM
Dec 9, 2021 05:43AM
Dec 9, 2021 01:30AM QIAGEN and Denovo Biopharma Partner to Develop Companion Diagnostic Test for the Treatment of Diffuse Large B-Cell Lymphoma (DLBCL)
Nov 29, 2021 05:48AM
Nov 29, 2021 01:10AM
Nov 2, 2021 04:05PM
Oct 22, 2021 06:00AM
Aug 9, 2021 04:05PM
Aug 6, 2021 01:19PM
Aug 6, 2021 01:15PM QIAGEN receives U.S. FDA emergency use authorization for rapid portable test that can analyze over 30 samples per hour for SARS-CoV-2 antigen
Jul 8, 2021 04:22PM
Jul 8, 2021 04:22PM
Jul 1, 2021 05:04PM
Jul 1, 2021 05:03PM
Jul 1, 2021 01:59AM
May 28, 2021 01:46PM
May 28, 2021 01:45PM QIAGEN Launches First FDA-approved Tissue Companion Diagnostic to Identify the KRAS G12C Mutation in NSCLC Tumours and Expand Precision Medicine Options in Lung Cancer
May 25, 2021 04:19PM
May 25, 2021 04:05PM
May 12, 2021 04:07PM
May 12, 2021 04:05PM
Apr 20, 2021 04:15PM
Apr 20, 2021 04:05PM
Mar 29, 2021 06:35AM Qiagen (QGEN) Granted FDA Emergency Use for NeuMoDx Multiplex Test to Quickly Identify Respiratory Viral Infection Consistent with COVID-19
Mar 29, 2021 02:00AM

326,823 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All